Rigel Pharmaceuticals Stock (NASDAQ: RIGL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 5.000 / 1.457M |
Day Range | - - - |
52 Wk Range | 0.712 - 1.960 |
Market Cap | $191.191M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 2.92% |
Days to Cover | 5.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rigel Pharmaceuticals (NASDAQ: RIGL) through any online brokerage.
Other companies in Rigel Pharmaceuticals’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Rigel Pharmaceuticals (NASDAQ: RIGL) was reported by Citigroup on Thursday, March 7, 2024. The analyst firm set a price target for 4.00 expecting RIGL to rise to within 12 months (a possible 266.97% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $1.09 last updated April 25, 2024 at 6:56 PM EDT.
There are no upcoming dividends for Rigel Pharmaceuticals.
Rigel Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Rigel Pharmaceuticals.
Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.